BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6422173)

  • 1. Participation of mast cell 5-hydroxytryptamine in the vasoconstrictor effect of neurotensin in the rat perfused hindquarter.
    Kérouac R; St-Pierre S; Rioux F
    Life Sci; 1984 Mar; 34(10):947-59. PubMed ID: 6422173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of mast cell mediators, vasoconstriction and edema in the isolated, perfused head of the rat following intracarotid infusion of neurotensin.
    Rioux F; Kérouac R; St-Pierre S
    Neuropeptides; 1985 Mar; 6(1):1-12. PubMed ID: 2581166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin stimulates histamine release from the isolated, spontaneously beating heart of rats.
    Rioux F; Kérouac R; St-Pierre S
    Life Sci; 1984 Jul; 35(4):423-31. PubMed ID: 6205239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of various drugs on the variations of blood pressure, hematocrit and plasma histamine caused by neurotensin and compound 48/80 in rats.
    Kérouac R; St-Pierre S; Rioux F
    Neuropeptides; 1982 Dec; 3(2):145-57. PubMed ID: 6131390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the histamine releasing effect of neurotensin in the rat heart.
    Rioux F; Kérouac R; St-Pierre S
    Peptides; 1985; 6(1):121-5. PubMed ID: 2581231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels.
    Carraway R; Cochrane DE; Lansman JB; Leeman SE; Paterson BM; Welch HJ
    J Physiol; 1982 Feb; 323():403-14. PubMed ID: 6178820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of histamine and adrenaline in vivo following intravenous administration of neurotensin.
    Oishi M; Ishiko J; Inagaki C; Takaori S
    Life Sci; 1983 May; 32(19):2231-9. PubMed ID: 6405112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of beta-endorphin-induced histamine release from rat serosal mast cells. Comparison with neurotensin, dynorphin and compound 48/80.
    Sydbom A
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):567-72. PubMed ID: 2469022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine release induced by neurotensin from rat peritoneal mast cells.
    Kurose M; Saeki K
    Eur J Pharmacol; 1981 Dec; 76(2-3):129-36. PubMed ID: 6174350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway rats.
    Hannon JP; Tigani B; Williams I; Mazzoni L; Fozard JR
    Br J Pharmacol; 2001 Apr; 132(7):1509-23. PubMed ID: 11264245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine release by neurotensin in the rat hindquarter: structure-activity studies.
    Kerouac R; St-Pierre S; Rioux F
    Peptides; 1984; 5(4):695-9. PubMed ID: 6208534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine and serotonin released from the rat perfused heart by compound 48/80 or by allergen challenge influence noradrenaline or acetylcholine exocytotic release.
    Fuder H; Ries P; Schwarz P
    Fundam Clin Pharmacol; 1994; 8(6):477-90. PubMed ID: 7536702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects on sympathetic neurotransmission of mast cell degranulation by compound 48/80 or antigen in the rat isolated perfused heart.
    Ries P; Fuder H
    Methods Find Exp Clin Pharmacol; 1994; 16(6):419-35. PubMed ID: 7530791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel secretion of endogenous 5-hydroxytryptamine and histamine from mast cells stimulated by vasoactive peptides and compound 48/80.
    Carraway RE; Cochrane DE; Granier C; Kitabgi P; Leeman E; Singer EA
    Br J Pharmacol; 1984 Feb; 81(2):227-9. PubMed ID: 6200170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of 5-hydroxytryptamine in the vasoconstrictor action of compound 48/80 in the rat femoral vasculature.
    Sakai K
    Br J Pharmacol; 1979 Mar; 65(3):363-6. PubMed ID: 427313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of neurotensin-stimulated mast cell secretion and carboxypeptidase A activity by the peptide inhibitor of carboxypeptidase A and neurotensin-receptor antagonist SR 48692.
    Miller LA; Cochrane DE; Feldberg RS; Carraway RE
    Int Arch Allergy Immunol; 1998 Jun; 116(2):147-53. PubMed ID: 9652308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor.
    Miller LA; Cochrane DE; Carraway RE; Feldberg RS
    Br J Pharmacol; 1995 Apr; 114(7):1466-70. PubMed ID: 7541694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin stimulates histamine release in in vivo skin 'blisters' in rats: an effect inhibited by cromolyn or somatostatin.
    Cochrane DE; Boucher W; Bibb P
    Int Arch Allergy Appl Immunol; 1986; 80(3):225-30. PubMed ID: 2424843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal mast cells modulate vascular and secretory responses in the intact adrenal gland of the rat.
    Hinson JP; Vinson GP; Pudney J; Whitehouse BJ
    J Endocrinol; 1989 May; 121(2):253-60. PubMed ID: 2547005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound 48/80 inhibits neurotensin-induced hypotension in rats.
    Quirion R; Rioux F; Regoli D; St-Pierre S
    Life Sci; 1980 Nov; 27(20):1889-95. PubMed ID: 6110157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.